193 related articles for article (PubMed ID: 23621615)
1. Mast cells in cutaneous tumors: innocent bystander or maestro conductor?
Biswas A; Richards JE; Massaro J; Mahalingam M
Int J Dermatol; 2014 Jul; 53(7):806-11. PubMed ID: 23621615
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
3. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression.
Reed JA; McNutt NS; Bogdany JK; Albino AP
J Cutan Pathol; 1996 Dec; 23(6):495-505. PubMed ID: 9001979
[TBL] [Abstract][Full Text] [Related]
4. Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis.
Bonish BK; Foreman KE; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1997 Nov; 16(1):52-8. PubMed ID: 9438908
[TBL] [Abstract][Full Text] [Related]
5. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
[TBL] [Abstract][Full Text] [Related]
6. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
7. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers.
Mauzo SH; Milton DR; Prieto VG; Torres-Cabala CA; Wang WL; Chakravarti N; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Brown RE; Aung PP
Ann Diagn Pathol; 2018 Jun; 34():151-154. PubMed ID: 29660567
[TBL] [Abstract][Full Text] [Related]
8. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
[TBL] [Abstract][Full Text] [Related]
9. The patient with a pigmented lesion.
Koh HK
Hosp Pract (Off Ed); 1986 Oct; 21(10A):47-9, 53-4. PubMed ID: 3095342
[No Abstract] [Full Text] [Related]
10. Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases.
Bugatti L; Filosa G
Clin Exp Dermatol; 2009 Dec; 34(8):e898-900. PubMed ID: 20055861
[TBL] [Abstract][Full Text] [Related]
11. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
12. [Pigmented skin tumors].
Lechner W
Krankenpfl J; 1980 Jan; 18(1):18-20. PubMed ID: 6247567
[No Abstract] [Full Text] [Related]
13. Recurrent atypical fibroxanthoma of the cheek.
Skoulas IG; Price M; Andrew JE; Kountakis SE
Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
[TBL] [Abstract][Full Text] [Related]
14. Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.
Brenn T
Head Neck Pathol; 2020 Mar; 14(1):109-120. PubMed ID: 31950467
[TBL] [Abstract][Full Text] [Related]
15. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
16. Aspiration biopsy cytology of primary cutaneous tumors.
Layfield LJ; Glasgow BJ
Acta Cytol; 1993; 37(5):679-88. PubMed ID: 8362578
[TBL] [Abstract][Full Text] [Related]
17. Major dermatologic malignancies encountered in a teaching hospital surgical department in South Nigeria.
Asuquo ME; Ngim O; Ugare G; Omotoso J; Ebughe G
Am J Clin Dermatol; 2008; 9(6):383-7. PubMed ID: 18973404
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous sarcomas and sarcomatoid neoplasms of the skin.
Wick MR; Fitzgibbon J; Swanson PE
Semin Diagn Pathol; 1993 May; 10(2):148-58. PubMed ID: 8396271
[TBL] [Abstract][Full Text] [Related]
19. Clinical simulators of melanoma.
Matz H; Orion E; Ruocco V; Wolf R
Clin Dermatol; 2002; 20(3):212-21. PubMed ID: 12074855
[No Abstract] [Full Text] [Related]
20. Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions.
Agarwal A; Gopinath A; Tetzlaff MT; Prieto VG
Am J Dermatopathol; 2017 Jul; 39(7):504-507. PubMed ID: 28609344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
